- Prevention and treatment of experimental breast cancer with the combination of a new selective estrogen receptor modulator, arzoxifene, and a new rexinoid, LG 100268. Suh, N., Lamph, W.W., Glasebrook, A.L., Grese, T.A., Palkowitz, A.D., Williams, C.R., Risingsong, R., Farris, M.R., Heyman, R.A., Sporn, M.B. Clin. Cancer Res. (2002)